Galenica AB

Galenica is a Swedish privately owned pharmaceutical company, authorized and audited by the Swedish Medical Product Agency. Galenica was founded in 1999 and has grown to 70 employees with expertise and balance between academic knowledge and industrial experience. Galenica is located in Medeon Science Park with 4000 m² state-of-the-art facilities. Our activities are divided into two business units: Contract Development Manufacturing Organization (CDMO) and Development and launching of own branded pharmaceutical products (Derma). Within CDMO (Contract Development Manufacturing Organization), Galenica supports and guides our partners in their pharmaceutical development programs and manufactures commercially niched products for our customers to bring to the market. We have vast expertise in pharmaceutical and analytical development as well as in production of Clinical Trial Material (CTM) for Phase I up to Phase III of all common non-sterile dosage forms. The Derma unit actively develops and launches our own pharmaceutical products which has a focus on derma, utilizing our state-of-the-art expertise in drug formulation, manufacturing, and quality control. Galenica has a proven track record when it comes to quality, knowledge and flexibility as well as keeping timelines. We combine state-of-the-art equipment with strong personal commitment, far-reaching clinical experience with tough perseverance, expertise in drug formulation with a solution-oriented determination. Since the start, we have supported and guided hundreds of clients in their pharmaceutical development programs and launched several self-made products.